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In a previous report, we described the in-hospi-
tal results for 1924 isolated carotid endarterectomy
(CEA) procedures that were performed by members
of our department from 1989 to 1995.1 On the
basis of a multivariable statistical model, we con-
cluded that the following three factors unfavorably
influenced the combined stroke and mortality rate
(CSM) in this series of patients: female gender (P =
.05), carotid reoperations for recurrent stenosis (P =
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Purpose: In an earlier report of our database for 1924 isolated carotid endarterectomies
(CEAs) from 1989 to 1995, multivariable analysis results indicated that the urgency of
operation unfavorably influenced the combined stroke and mortality rate (CSM). This
study was conducted in an attempt to document the features that contribute to periop-
erative complications and late outcome in 314 patients for whom CEA was considered
to be nonelective because of the severity of previous symptoms, carotid stenosis, or med-
ical comorbidities.
Methods: All the hospital charts and outpatient records were reviewed retrospectively for
the 209 men and 105 women who had undergone nonelective CEAs (median age, 69
years). Information regarding the clinical risk factors, the operative indications (CHAT
classification), the severity and distribution of carotid disease, and the surgical manage-
ment were analyzed to assess the impact on the 30-day CSM and on the long-term sur-
vival rate and neurologic events during a median follow-up period of 34 months.
Results: Previous symptoms had occurred in 285 patients (91%) and included cortical
transient ischemic attacks in 47%, amaurosis fugax in 20%, completed strokes in 14%,
unstable strokes in 2%, and nonspecific or miscellaneous symptoms in 8%. Preoperative
angiography was performed in 308 patients (98%), which confirmed the presence of 80%
to 99% ipsilateral carotid stenosis in 79% of the patients and >90% stenosis in 43%. The
median interval between presentation and surgical treatment was 2 days, but 48% of the
314 CEAs were performed within 24 hours of presentation. The 30-day CSM was 6.7%
and ranged from 3.4% for 29 patients with severe asymptomatic carotid stenosis to 14%
for those patients with unstable strokes. The cardiac and pulmonary risk factors were the
only variables that were related statistically to the CSM. During the follow-up period,
the risk for ipsilateral stroke was significantly higher in women (risk ratio [RR], 2.38;
95% confidence interval [CI], 1.02 to 5.56; P = .04) and in patients with higher gradi-
ents of cardiac and pulmonary risk factors (RR, 2.8; 95% CI, 1.6 to 4.8 per gradient
increase; P < .001). The risk was significantly lower in patients who had undergone vein
patch angioplasty (RR, 0.29; 95% CI, 0.12 to 0.71; P = .006) in comparison with syn-
thetic patching. However, 38 of the 55 patients (69%) who underwent synthetic patch-
ing also had widespread atherosclerosis for which the saphenous veins already had been
harvested for coronary bypass grafting surgery or infrainguinal revascularization.
Conclusion: In our experience, the perioperative risk of nonelective CEA primarily is
determined by incidental cardiopulmonary disease. Vein patch angioplasty appears to
enhance late results, but the late stroke rate associated with synthetic patching also may
have been influenced by the extent of vascular disease in our study group. (J Vasc Surg
1999;30:618-31.)
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.024), and the perceived urgency of surgical inter-
vention (P = .026). Furthermore, female gender (P
= .030), the use of synthetic material rather than
autogenous saphenous vein for carotid patching (P
= .015), and, once again, urgent indications for sur-
gical treatment (P = .040) also were associated with
higher risks for perioperative stroke alone. Because
of the apparent importance of urgency with respect
to outcome, the purpose of this study was to provide
additional information regarding 30-day complica-
tion rates and the late results of nonelective CEA at
our center.
PATIENTS AND METHODS
At the discretion of each attending surgeon, a
total of 332 of the 1924 CEAs (17%) in our original
database were designated as either semi-elective (n =
287) or emergent (n = 27) at the time they were
entered into our prospective registry. Twelve of these
operations were performed in conjunction with
simultaneous brachiocephalic arterial reconstruction
and were excluded from further consideration. Six of
the remaining 320 patients underwent bilateral non-
elective CEAs at some interval during the 7 years in
which this series was collected. To facilitate the statis-
tical analysis of patient-related features, the second
bilateral procedures also have been omitted from the
cohort of 314 CEAs described in this report.
Each of the 314 hospital charts and outpatient
records was reviewed retrospectively to document
information regarding patient demographics, preop-
erative risk factors, surgical indications, operative
technique, perioperative management, early compli-
cations, late outcome, and the results of both preop-
erative and postoperative imaging studies. Additional
information concerning survival and neurologic status
was obtained with telephone contact with patients,
their families, or their referring physicians for all the
patients who had not undergone reevaluation in our
department within the previous 6 months.
Clinical features
The study cohort included 209 men (67%) and
105 women, with a median age of 69 years (range,
44 to 93 years; mean, 69 ± 8.7 years). The median
length of time between the initial surgical consulta-
tion and the date of CEA was 2.0 days (range, 0 to
24 days; mean, 2.8 ± 3.3 days), but 150 of the 314
operations (48%) were performed within 24 hours of
consultation. The surgical treatment was performed
in 3 days or less for 234 patients (group I, 75%), in
4 to 7 days for 54 patients (group II, 17%), and in 8
days or more for 26 patients (group III, 8%).
The preoperative risk factors (Table I) have been
classified to comply with reporting standards sug-
gested by an ad hoc committee of the Society for
Vascular Surgery and the North American Chapter of
the International Society for Cardiovascular Surgery
(SVS/ISCVS-NA).2 In consideration of the three
factors (cardiac, pulmonary, and renal) that have the
most obvious implications regarding surgical mortal-
ity, the composite risk score for the patients in group
III was significantly higher than the score for those
patients in group I (P < .001, with Kruskal-Wallis
test). The recommendations of the SVS/ISCVS-NA
committee also were used to stratify the overall cere-
brovascular profile according to the international
CHAT classification (Table II). With this system,
which was proposed by Courbier3 in 1984 and sub-
sequently was modified by Bernstein et al4,5 to
resemble TNM tumor staging, the principal cate-
gories are as follows: C, the current neurologic status
or the most recent neurologic event within the pre-
ceding 12 months; H, the remote neurologic status
or dominant event more than 1 year before CEA; A,
a description of the index arterial lesion, including its
Table I. Risk factor categories*
0 (None) 1 (Mild) 2 (Moderate) 3 (Severe)
No. of No. of No. of No. of
patients % patients % patients % patients %
Diabetes 243 77 53 17 18 6 0 — 
Tobacco use 190 60 42 13 36 12 46 15 
Hypertension 121 39 130 41 54 17 9 3 
Hyperlipidemia 211 67 51 16 5 2 47 15 
Cardiac risk 133 42 90 29 80 26 11 3 
Renal risk 257 82 49 16 4 1 4 1 
Pulmonary risk 288 92 17 5 4 1 5 2 
*Ad Hoc Committee on Reporting Standards, Society for Vascular Surgery/North American Chapter, International Society for
Cardiovascular Surgery.2
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location and cause; and T, the documentation of tar-
get organ infarction in the brain (or less frequently,
the retina), usually on the basis of computed tomo-
graphic (CT) or magnetic resonance (MR) scanning
results. Most of the primary designations in each of
these categories also may be substratified with five to
seven additional descriptors, most of which are not
applicable to patients with atherosclerotic carotid
bifurcation disease.
As indicated in Table II, recent transient ischemic
attack (TIA) or amaurosis fugax had occurred in 208
of our patients (67%), completed stroke with residual
deficit in 31 patients (9%), “temporary” stroke with
full recovery within 3 weeks in 16 patients (5%), unsta-
ble (fluctuating) stroke in seven patients (2%), and
either global cerebral ischemia (n = 12) or miscella-
neous symptoms (n = 11) each in 4% of patients. Only
29 patients (9%) had severe but asymptomatic carotid
stenosis. Most of the patients (n = 251; 80%) had been
symptom free 1 year or more earlier, and all had typi-
cal atherosclerotic carotid lesions. Preoperative CT or
MR scans were available for 149 patients (47%), and
results revealed cortical or lacunar infarcts in 68 cases
(22%), 50 of which were ipsilateral to the subsequent
nonelective CEA. In addition, 72 patients (23%) had a
history of previous CEA on either the ipsilateral (n =
28; 9%) or the contralateral (n = 44; 14%) side.
Preoperative carotid imaging
The severity of carotid stenosis documented with
preoperative duplex ultrasound scanning and digital
subtraction angiography (DSA) is presented in Table
III. Although the findings generally were concor-
dant, DSA maintained its expected superiority to
duplex scanning with respect to the distinction
between subtotal stenosis and complete occlusion of
the internal carotid artery (ICA) in a small group of
patients with the angiographic “string sign.” It often
was impossible to determine retrospectively whether
the many surgeons and radiologists who interpreted
the DSA films used the diameter of the distal ICA or
the estimated contour of the carotid bulb as their
reference point for measuring the degree of stenosis.
Nevertheless, the fact that 248 patients (79%) had at
least 80% stenosis with angiography, including 135
Table II. CHAT classification*
Current status (<1 year) History (>1 year) Artery Target
No. of No. of No. of No. of
patients % patients % patients % patients %
Asymptomatic (Co) 29 9 (Ho) 251 80 Atherosclerotic lesion(s) No lesion (To) 77 24
Amaurosis (C1a) 62 20 (H1a) 12 4 Appropriate (A1a) 117 37 Appropriate lesion
Infarct (T1i) 42 13
Cortical Lacunar (T1j) 2 1
TIA (C1b) 146 47 (H1b) 18 6 Other pathway (A2a) 2 1 Retinal (T1r) 6 2
Stroke
Temporary (C2b) 16 5 (H2b) 3 1 Other territory
Permanent Combined (A3a) 195 62 Infarct (T2i) 13 4
Minor (C3b) 23 7 (H3b) 15 4 Lacunar (T2j) 3 1
Major (C4b) 8 2 (H4b) 11 4
Unstable stroke (C6,7,8) 7 2 0 — Combined lesions
Infarct (3i) 8 3
Nonspecific (C3e) 12 4 0 — No CT/MR scan 159 51
All others 11 4 4 1 All others 4 1
TIA, Transient ischemic attack; CT/MR, computed tomographic/magnetic resonance.
*Ad Hoc Committee on Reporting Standards, Society for Vascular Surgery/North American Chapter, International Society for
Cardiovascular Surgery.2
Table III. Preoperative carotid imaging
Ipsilateral Contralateral
No. of No. of
Severity of stenosis patients % patients %
Duplex ultrasound scanning
<60% 31 10 176 56
60% to 79% 38 12 34 11
80% to 99% 202 64 47 15
ICA occlusion 11 4 25 8
No duplex scanning 32 10 32 10
Digital angiography
<60% 17 5 194 62
60% to 79% 42 13 31 10
80% to 99% 248 79 49 15
(>90%) (135) (43) (33) (10)
ICA occlusion 1 0.3 28 9
No angiogram 6 2 12 4
ICA, Internal carotid artery.
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(43%) with >90% stenosis, confirms that nonelective
CEA ordinarily was performed for advanced disease
irrespective of the method used for its measurement.
In addition to extracranial carotid stenosis, DSA
results revealed ulcerated plaques in 64 patients
(20%), intraluminal ICA thrombus in nine (3%), and
≥50% stenosis of the ipsilateral carotid siphon in 44
(14%). On the basis of the angiographic findings or
the associated neurologic symptoms, 210 of the 314
patients (67%) underwent intravenous heparin ther-
apy in the hospital before CEA.
Operative management
With exceedingly rare exceptions, nearly all the
operations were conducted with general anesthesia.
Intraluminal shunts (Heyer-Schulte Corp, Goleta,
Calif) were used in 307 patients (98%). Carotid patch
angioplasty was performed in 303 patients (96%), with
the greater saphenous vein harvested from the groin in
246 patients (78%), synthetic material in 55 patients
(17%), and either the internal jugular vein or advance-
ment of the carotid bifurcation with the external
carotid artery as a patch in two patients (0.6%). The
remaining 11 patients (4%) underwent primary arteri-
otomy closure.
No intraoperative imaging was performed. The
patients were awakened while still in the operating
room to assess neurologic status and then were
observed for 6 hours in the recovery area before being
transferred to a dedicated vascular nursing unit. The
median postoperative length of stay in the hospital was
3.0 days (range, 2 to 50 days; mean, 4.8 ± 5.1 days.)
Statistical methods
The univariate association between outcome
events and each of 25 baseline variables was assessed
with the χ2 test or with Fisher exact test for categori-
cal factors and with the Mantel-Haenszel test for trend
for ordinal factors coded on a scale of none, mild,
moderate, or severe (Table I). Cox proportional haz-
ards regression modeling and Kaplan-Meier method
analysis were used to assess the association between the
same baseline variables and each of the following long-
term, time-to-event outcomes: first neurologic event
(overall, ipsilateral, and contralateral), first stroke
(overall, ipsilateral, and contralateral), and death. Risk
ratios and 95% confidence intervals (CIs) were calcu-
lated for each variable. A significance criterion of P
value less than .01 was used for all univariate analyses
to reduce the possibilities of concluding significance
caused by chance findings alone (type 1 errors).
One or more multivariable models were fit for
each of the outcomes that were assessed with univari-
ate analysis. Backwards stepwise regression was used
for both the logistic regression model (early stroke or
death) and the Cox models, with a P value of .05 as
the criterion for removal from the model. All the vari-
ables that had been found to be significant at the level
of P less than .10 in the univariate analyses were con-
sidered for the multivariable models. For disease vari-
ables that were classified both on a yes/no basis and
on the gradient of none, mild, moderate, and severe,
the gradient version of the variable was preferred if
both had been found to be significant univariately.
The c-index, a number between 0 and 1 that indi-
cates how well the model fits the data, was determined
for each Cox model.6 The c-index reflects the propor-
tion of pairs of observations in which, for example,
patients predicted with the model to have longer sur-
vival actually do survive longer and vice versa. A c-
index of 0.50 would be expected by chance, but a c-
index of 0.75 would represent a “good” model and a
value of 0.85 or 0.90 would be even more dependable.
The c-index is calculated from data pairs in which
either both patients have the outcome event under
consideration or the patient without the event survives
at least as long as the patient with the event. Therefore,
the usefulness of the c-index depends in part on the
percentage of observed pairings that can be used in its
calculations, which can be quite small when the out-
come event is rare. With circumstances in which, for
instance, fewer than 50% of the pairings can be used,
the c-index is less meaningful.
RESULTS
Early complications
Only two deaths (0.6%) occurred in the hospital.
One of these patients required CEA because of an
unstable stroke after total laryngectomy for anaplas-
Table IV. Early postoperative complications
30-day events No. of patients % 95% CI
Mortality 6 1.9 0.7 to 4.1
Stroke 15 4.7 2.7 to 7.8
Ipsilateral 13 4.1 2.2 to 7.0
Contralateral 2 0.6 0.1 to 2.3
Minor 7 2.2 0.9 to 4.5
Major 8 2.5 1.1 to 5.0
CT documentation 12 3.8 2.0 to 6.6
Ischemic 10 3.2 1.5 to 5.8
Hemorrhagic 2 0.6 0.1 to 2.3
ICA thrombosis 4 1.2 0.3 to 3.2
Hyperperfusion syndrome 3 1.0 0.2 to 2.8
Minor stroke 1 0.3
Major stroke 1 0.3
CI, Confidence interval; CT, computed tomographic scanning;
ICA, internal carotid artery.
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tic carcinoma and died with local metastases and
sepsis caused by that procedure. The other patient
was a 90-year-old woman in whom refractory con-
gestive heart failure developed. Four additional
deaths (1.3%) occurred within 1 month after hospi-
tal discharge, however, for an overall 30-day mortal-
ity rate of 1.9%. One of these patients died as the
result of a previous contralateral stroke, another had
a fatal myocardial infarction, and the remaining two
patients died with complications after staged coro-
nary artery reoperations.
As summarized in Table IV, there were 15 early
strokes (4.7%) within 30 postoperative days. Most of
these involved the cerebral hemisphere ipsilateral to
CEA and were ischemic, rather than hemorrhagic,
with CT scanning. Although formal neurologic scor-
ing was inconsistently recorded, about half of the
deficits were associated with major functional impair-
ment. Ten of the strokes (3.2%) occurred in the hos-
pital, including four patients with postoperative ICA
occlusions, one with intraoperative thrombosis of the
carotid shunt, and another whose deficit was discov-
ered only after subsequent cardiac catheterization
and probably was not causally related to CEA. The
four documented ICA occlusions occurred in the
patient with carotid bifurcation advancement and in
three other patients for whom immediate thrombec-
tomy and remedial procedures were performed
(repair of an ICA “kink” [n = 1] and vein patch
angioplasty after either primary closure [n = 1] or
synthetic patching [n = 1] during the original opera-
tion). The remaining four patients had normal
carotid imaging results after the onset of the neuro-
logic events, which, therefore, were presumed to be
embolic in origin. Five additional patients (1.5%) had
strokes within 30 days after discharge from the hos-
pital. Two of these strokes occurred in conjunction
with cerebral hyperperfusion syndrome, but the
cause of the other three delayed strokes remained
unknown even after further investigation with duplex
ultrasound scanning and carotid DSA.
The 21 fatal and nonfatal events that represent the
30-day CSM are categorized with respect to the pre-
operative CHAT classification in Table V. The lowest
CSMs appear to be concentrated among patients who
either were asymptomatic before surgery (C0) or who
had unilateral carotid stenosis that was appropriate to
their previous symptoms in the absence of any other
extracranial arterial lesions (A1a). In general, however,
these data failed to suggest obvious trends in surgical
risk, possibly because of the small sample size in many
of the CHAT subsets. There were 129 different com-
binations of C, H, A, and T when each of our 314
patients was classified according to all four CHAT cat-
egories, with 92 of these subsets (71%) containing
only a single patient. The 30-day complication rates
for all the subsets that are comprised of at least five
patients are presented in Table VI. We are reluctant to
draw any conclusions from these data, but they may
be of some comparative interest to other investigators
in the future.
The 30-day CSM was 6.4% for the 234 patients in
group I, 3.7% for the 54 patients in group II, and 15%
for the 26 patients in group III (P = .15). Table VII
contains additional information regarding the 47
patients who had stable preoperative strokes in carotid
Table V. Combined stroke and mortality rates
Current status (<1 year) History (>1 year) Artery Target
No. of No. of No. of No. of
patients % patients % patients % patients %
Asymptomatic (Co) 1 3.4 (Ho) 17 6.8 Atherosclerotic lesion(s) No lesion (To) 5 6.5
Amaurosis (C1a) 3 4.8 (H1a) 2 17 Appropriate (A1a) 4 3.4 Appropriate lesion
Infarct (T1i) 4 9.5
Cortical Lacunar (T1j) 0 —
TIA (C1b) 11 7.5 (H1b) 0 — Other pathway (A2a) 0 — Retinal (T1r) 1 17
Stroke Other territory 15
Temporary (C2b) 1 6.2 (H2b) 0 — Infarct (T2i) 2 —
Permanent Combined (A3a) 17 8.7 Lacunar (T2j) 0
Minor (C3b) 2 8.7 (H3b) 1 6.7
Major (C4b) 0 — (H4b) 1 9.1
Unstable stroke (C6,7,8) 1 14 Combined lesions
Infarct (3i) 0 —
Nonspecific (C3e) 0 — No CT/MR scan 8 5.0
All others 2 18 0 — All others 1 25
TIA, Transient ischemic attack; CT/MR, computed tomographic/magnetic resonance.
JOURNAL OF VASCULAR SURGERY
Volume 30, Number 4 Tretter et al 623
vascular territories according to the CHAT classifica-
tion (C2b, C3b, C4b). Because all of these patients
underwent nonelective CEA by definition, the timing
between their strokes and their operations was influ-
enced almost entirely by the urgency with which they
or their referring physicians requested surgical consul-
tation. This interval was 3 weeks or less in 32 patients
(68%), and it was 4 weeks or longer in 15 patients
(32%). Preoperative CT scan results of the brain
revealed new infarcts in nine patients (20%) and old
infarcts in 13 patients (27%). No lesions were discov-
ered in 21 of the 43 patients (49%) for whom CT
scans were obtained. Four patients underwent opera-
tions on the side opposite to previous strokes caused
by contralateral ICA occlusions. The CSM for all 47
patients with stable preoperative strokes was 6.4%.
Table VI. Specific CHAT results (30 days)
Stroke Death CSM
CHAT category No. of patients No. of patients % No. of patients % No. of patients %
C0 HO A1a Tvoid 9 0 — 0 — 0 —
C0 HO A3a Tvoid 16 1 6.2 0 — 1 6.2
C1a HO A1a Tvoid 14 0 — 0 — 0 —
C1a HO A3a To 7 0 — 0 — 0 —
C1a HO A3a Tvoid 26 1 3.8 2 7.7 3 12
C1ab HO A3a Tvoid 8 0 — 0 — 0 —
C1b HO A1a To 12 2 17 0 — 2 17
C1b HO A1a Tvoid 20 1 5 0 — 1 5
C1b HO A3a To 19 3 16 0 — 3 16
C1b HO A3a Tvoid 33 1 3 2 6.1 3 9.1
C3b HO A3a T1i 9 0 — 0 — 0 —
All others 141 6 4.3 2 1.4 8 5.7
CSM, Combined stroke and mortality rate; Tvoid, no retinal lesions or computed tomographic/magnetic resonance scans to qualify for
classification in this category.
Table VII. Stable preoperative strokes
CHAT classification
C2b C3b C4b Total
No. of patients % No. of patients % No. of patients % No. of patients %
Patients 16 34 23 49 8 17 47 100
Interval between stroke and operation
<1 week 5 32 2 9 1 12 8 17
1 to 3 weeks 9 56 14 61 1 12 24 51
4 to 6 weeks 1 6 3 13 3 38 7 15
>6 weeks 1 6 4 17 3 38 8 17
Side of stroke versus side of operation
Ipsilateral 16 100 20 87 7 88 43 91
Contralateral 0 — 3 13 1 12 4 9
Preoperative CT findings
Deep infarct (new) 2 12 2 9 1 12 5 11
Cortical infarct (new) 1 6 3 13 0 — 4 9
Old infarct only 3 19 8 35 2 25 13 27
No infarct 9 57 7 30 5 63 21 44
No CT scan 1 6 3 13 0 — 4 9
Perioperative complications
Mortality 1 6.2 1 4.3 0 — 2 4.3
Stroke 0 — 1 4.3 0 — 1 2.1
Hyperperfusion syndrome 0 — 0 — 0 — 0 —
CT, Computed tomographic scan.
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Late outcome
With the exception of the six postoperative deaths
and the five other patients (1.6%) who had been lost to
follow-up, long-term results are available for 303 of
the 314 patients at a median interval of 34 months
(maximum, 91 months; mean, 37 ± 24 months).
There were 61 late deaths (20%), which were caused
by cardiac disease in 16 patients (5.3%), cancer in eight
patients (2.6%), fatal strokes in three patients (1.0%),
and miscellaneous or undetermined events in the
remaining 34 patients (11%). In consideration of all 67
early and late deaths, the Kaplan-Meier method esti-
mates for long-term survival rates were 93% (95% CI,
90% to 96%) at 1 year, 82% (95% CI, 77% to 87%) at
3 years, and 70% (95% CI, 63% to 77%) at 5 years.
No neurologic symptoms referable to the operated
carotid artery have occurred in 286 patients (94%),
whereas eight patients (2.6%) have had ipsilateral
amaurosis fugax or cortical TIAs and nine patients
(3.0%) have had ipsilateral strokes. A total of 10
patients (3.3%) have had contralateral neurologic com-
plications. In consideration of all early and late events,
the Kaplan-Meier method 5-year risk rate was 17%
(95% CI, 11% to 23%) for any first neurologic symp-
tom (ipsilateral, 13%; contralateral, 6%), and was 9%
(95% CI, 3% to 13%) for any first stroke (ipsilateral,
7%; contralateral, 2%). Follow-up duplex scanning was
performed on one or more occasions in 165 of the
303 patients (54%). According to their most recent
scan results, 135 of these patients (82%) have no evi-
dence of recurrent stenosis. Mild to moderate (<60%)
stenosis has been identified in 23 patients (14%), and
≥60% stenosis (n = 3) or ipsilateral ICA occlusions (n
= 4) have been discovered in seven (4.2%). Forty-two
patients (14%) have undergone contralateral CEA, but
only five (1.6%) have required reoperations on the
same side as their original nonelective CEAs.
Statistical analysis
The results of multivariable analysis with Cox
proportional hazards regression model are summa-
rized in Table VIII.
Table VIII. Multivariable analysis (Cox regression)
C-index 
Outcome Risk ratio 95% CI P value (pairs used)
Perioperative (30-day) stroke/mortality
Cardiac risk* 1.9† 1.2 to 3.2 .011 0.71
Pulmonary status* 2.2† 1.6 to 3.2 <.001 (100%)
Late survival
Renal function 2.8 1.6 to 4.8 <.001 0.76
(creatinine level, >1.5 mg/dL) (52%)
Pulmonary status* 1.7 1.2 to 2.4 .004
Age deciles .020
<60 years 1.0
60 to 69 years 0.84 0.33 to 2.2
70 to 79 years 1.3 0.51 to 3.2
≥80 years 2.7 1.0 to 7.0
First neurologic event
Female gender 2.0 1.07 to 3.7 .029 0.74
Pulmonary status* 2.9 1.9 to 4.3 <.001 (44%)
Vein patch 0.29 0.15 to 0.55 <.001 
First ipsilateral neurologic event
Female gender 2.4 1.2 to 5.0 .012 0.80
Pulmonary status* 2.4 1.5 to 4.0 <.001 (46%)
Vein patch 0.27 0.13 to 0.70 .005
First contralateral neurologic event
Pulmonary status* 3.4 1.8 to 6.3 <.001 0.90
≥80% contralateral carotid stenosis 7.2 2.0 to 26.8 .003 (28%)
First stroke
Female gender 2.4 1.05 to 5.3 .057 0.84
Pulmonary status* 2.6 1.5 to 4.4 <.001 (41%)
Vein patch 0.30 0.12 to 0.71 .005
First ipsilateral stroke
Female gender 2.4 1.02 to 5.6 .044 0.86
Pulmonary status* 2.8 1.5 to 4.8 <.001 (44%)
Vein patch 0.28 0.11 to 0.71 .006
CI, Confidence interval.
*Considered as a continuous variable (0 to 3; Table I), with reference to the next less severe category.
†Odds ratio.
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Perioperative (30-day) combined stroke and
mortality rate. Of the 25 baseline variables that
were studied, only the preoperative cardiac and pul-
monary risk factors appeared to influence the CSM
on univariate testing (Appendix). Both of these fea-
tures also were found to be significant in multivari-
able models, and the incremental CSMs within each
of these two categories were consistent with their
SVS/ISCVS-NA classifications (Table I). The CSMs
for cardiac risk (none, mild, moderate, and severe)
were 3.8% (5 of 133), 5.6% (5 of 90), 10% (8 of 80),
and 27% (3 of 11), respectively, and the CSMs for a
comparable stratification of pulmonary risk were
5.2% (15 of 288), 12% (2 of 17), 25% (1 of 4), and
60% (3 of 5), respectively.
Late survival rate. Overall late survival rate was
calculated on the basis of both perioperative and long-
term deaths. Although the aggregate mortality rate
was marginally influenced by cardiac risk expressed as
a continuous variable on univariate analysis (risk ratio
[RR], 1.3; 95% CI, 1.0 to 1.7; P = .04), this factor did
not prove to be significant on multivariable modeling.
Consequently, only the preoperative renal function,
the pulmonary status, and the age decile had signifi-
cant effects on late survival rates.
Neurologic outcome. The late neurologic out-
come also was determined on the basis of both peri-
operative and long-term complications. To avoid the
potential confusion of multiple complications in a few
patients, only the initial neurologic symptom (ie,
stroke, cortical TIA, or amaurosis fugax) or stroke was
considered as an index event for statistical purposes. As
indicated in Table VIII, female gender and chronic
obstructive pulmonary disease (COPD) unfavorably
influenced the risks for any first neurologic event, ipsi-
lateral neurologic event, stroke, or ipsilateral stroke.
The incidence of contralateral neurologic events pri-
marily was related to COPD and the severity (≥80%)
of contralateral carotid stenosis. The number of con-
tralateral strokes was too small for adequate analysis.
Diabetes and intraoperative carotid shunting appeared
to be associated with certain outcome events on uni-
variate testing, but the significance of these relation-
ships was not confirmed with multivariable models.
Carotid patch material. The 30-day CSM was
similar for patients who underwent vein patching
(15 of 247; 6.0%), synthetic patching (5 of 55;
9.1%), and primary arteriotomy repair or bifurcation
advancement (1 of 12; 8.3%), but the use of a vein
patch consistently was associated with superior long-
term neurologic results (Table VIII). According to
Kaplan-Meier method estimates, vein patch angio-
plasty was associated with significant freedom from
any first neurologic event (Figs 1,2) or stroke (Figs
3,4) in comparison with synthetic patching. It must
be noted, however, that the choice of patch materi-
al was determined by our preference for vein patch-
ing and the availability of the greater saphenous vein
in the groin for this purpose. These veins already had
been harvested for coronary bypass grafting surgery
or lower extremity revascularization in 38 of the 55
patients (69%) for whom synthetic carotid patches
Fig 1. Kaplan-Meier method estimates of freedom from any first neurologic event. Numbers
in parentheses indicate patients still eligible for consideration.
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subsequently were used during nonelective CEA.
Five-year (Kaplan-Meier method) survival rates were
60% (95% CI, 42% to 77%) for this group and 72%
(95% CI, 64% to 80%) for the 246 patients who
underwent saphenous vein patching (P = .29).
DISCUSSION
The limitations of our data are generic to most
retrospective reviews in which clinical management
has been determined by individual patient characteris-
tics and surgeon preferences, rather than by a formal
treatment protocol. The designation that these partic-
ular 314 CEAs were nonelective in nature was entire-
ly at the discretion of each attending surgeon, and,
although it primarily was influenced by the severity of
carotid stenosis in patients who were symptomatic, it
also took into account the presence of medical
comorbidities that might have discouraged truly elec-
tive intervention in less compelling circumstances.
Furthermore, an unknown number of patients with
recent strokes, impressive residual deficits, or large
cortical infarcts on CT/MR scanning selectively
underwent delayed CEA several weeks after initial
presentation and are not included in this report.
Finally, the choice of patch material for arteriotomy
closure largely was determined by the availability of
the greater saphenous vein in either groin, thus lead-
ing to a cautious interpretation of our findings regard-
ing the relationship between synthetic patches and
long-term outcome. With the concession of these
constraints, however, our experience with nonelective
CEA lends itself to several conclusions for comparison
with the previous literature on this topic.
According to our statistical analysis, the 30-day
CSM was determined to a greater extent by pre-exis-
tent cardiopulmonary risk factors than by any other
demographic feature, the preoperative neurologic sta-
tus, or such anatomic considerations as the severity of
ipsilateral and contralateral carotid stenosis, plaque
ulceration, intraluminal thrombus, or intracranial
arterial disease (Appendix). The fact that the 30-day
mortality rate in this cohort (1.9%) was approximate-
ly four times higher than the in-hospital mortality rate
(0.5%) for our overall series of 1924 isolated CEAs
implies that some patients who required nonelective
CEA might not have been accepted as candidates for
elective intervention. The differences between the
perioperative stroke rates for these two groups were
less striking: 3.4% (nonelective) versus 1.3% (overall)
for patients with asymptomatic carotid stenosis, 4.8%
versus 2.5% for those patients with previous amauro-
sis fugax or cortical TIAs, and 3.7% versus 3.0% for
those patients with prior strokes. Fredericks et al7 and
Berman et al8 also have reported perioperative stroke
risk rates of 3% or less for patients with angiographic
“string signs,” and Wilson et al9 encountered no
complications after urgent CEAs in a small subset of
12 patients in whom crescendo TIAs developed while
the patients were under medical management in the
setting of a randomized trial. Other investigators have
suggested that the presence of intraluminal thrombus
is associated with such a high surgical stroke rate (25%
Fig 2. Kaplan-Meier method estimates of freedom from any first ipsilateral neurologic event.
Numbers in parentheses indicate patients still eligible for consideration.
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to 36%) that CEA should be preceded by several
weeks of anticoagulation therapy even in patients who
are symptomatic.10-12 There are scant data with which
to test the merit of this unconventional approach,
however, and most surgeons probably continue to
consider free thrombus as an indication for immediate
CEA with minimal manipulation of the carotid bulb
during preliminary dissection. Only nine of our
patients had intraluminal thrombus, one of whom
(11%) had a perioperative stroke.
In comparison with those patients with transient
symptoms, the patients with a history of previous
strokes seem to have a higher incidence rate of com-
plications in conjunction with CEA under any cir-
cumstances.13-15 The timing of CEA after a recent
stroke has generated particular controversy ever since
the Joint Study of Extracranial Arterial Occlusion dis-
closed a mortality rate of 42% for 50 operations per-
formed within 2 weeks of antecedent strokes with
altered levels of consciousness in 1969.16 Possibly
because of this landmark cooperative study, it became
standard practice for nearly two decades to delay CEA
for at least 4 to 6 weeks after a stroke, even after CT
scanning had been introduced as a means to discrim-
inate the extent of cerebral infarction. Since the mid
1980s, several reports have shown that prompt CEA
may be performed safely in alert patients who have
stable neurologic deficits and either normal CT scan
results or only small documented infarcts.17-23 Our
data generally are consistent with the results described
in these reports: 32 of our 47 nonelective CEAs
(68%) in patients with recent strokes were performed
within 3 weeks of their index events, with periopera-
tive stroke and mortality rates of 2.1% and 4.3%,
respectively. Only nine of these 47 patients (20%) had
new infarcts shown on their preoperative CT/MR
scan results, however, which reflects our traditional
preference for a staging interval that is slightly longer
for many patients with infarcts exceeding 2 cm in
diameter with CT/MR scanning. This preference
may be arbitrary, but it appears to be associated with
a low risk for cerebral hyperperfusion syndrome or
hemorrhagic infarction, and it is shared by others.24
Only seven of our nonelective operations were
performed for unstable strokes, with worsening of the
preoperative neurologic deficit in one of these
patients (14%). These seven patients represented 0.4%
of our entire experience with 1924 isolated CEAs
from 1989 through 1995, as compared with a similar
figure of 1% or less in two earlier multicentered
series.13,14 The apparent reluctance to consider such
patients for immediate CEA probably can be
explained on the basis of an uncertain prognosis irre-
spective of their management. The previous literature
indicates that the mortality rate is approximately 10%
for either surgical or medical treatment and that an
unfavorable outcome, including death or a fixed neu-
rologic deficit, can be expected in about 45% and
70%, respectively.25,26 Consequently, there may be
reason to believe that nearly twice as many of the
remaining patients might be improved with urgent
CEA provided their severe carotid stenosis is recog-
Fig 3. Kaplan-Meier method estimates of freedom from any first stroke. Numbers in paren-
theses indicate patients still eligible for consideration.
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nized and repaired within a reasonable interval—usu-
ally, though not always, a matter of hours—after the
onset of their initial symptoms. Like most reports
from a single institution, however, our data are insuf-
ficient to clarify this issue.
The cumulative late mortality rate for our 314
patients (30% at 5 years) is typical for such patients
and was related statistically to advancing age, COPD,
and renal dysfunction. Nevertheless, the 5-year ipsi-
lateral stroke rate was only 7%, and serious (≥60%)
recurrent carotid stenosis has been discovered in just
4% of the 165 patients who returned for duplex scan
surveillance. Pulmonary disease also influenced the
incidence of any late stroke or neurologic symptom
on multivariable testing, together with female gender
and the use of a vein patch during CEA. We first
found more than 10 years ago that, at least in our
hands, vein patching was associated with a significant
reduction in the risks for perioperative stroke, early
ICA occlusion, and recurrent stenosis in comparison
with a nonrandomized cohort of patients who under-
went primary arteriotomy closure.27 Nearly simulta-
neously, Eikelboom et al28 published the results of
their seminal randomized trial in which vein patch
angioplasty also was shown to have a significantly
lower recurrence rate than primary closure, especially
in women. In 1997, Counsell et al29 collated the data
from Eikelboom et al28 and from five subsequent ran-
domized trials that compared primary closure with
any type of patch angioplasty (vein or synthetic) and
found, in aggregate, that patching seemed to confer
significant benefit with respect to the incidence of
perioperative or late ipsilateral stroke, any late stroke,
late stroke or death, and recurrent carotid stenosis.
Most recently, Moore et al30 reported that patch
angioplasty (again, vein or synthetic) was the single
variable that consistently was associated with signifi-
cant protection from recurrent stenosis among
patients who were randomized to surgical treatment
in the Asymptomatic Carotid Atherosclerosis Study.
The lingering controversy regarding carotid patch-
ing probably will not be resolved until a conclusive,
prospectively randomized, multicentered trial is con-
ducted.29 In the meantime, our experience with the
314 nonelective CEAs reported herein is presented as
an independent observation suggesting that vein
patches may provide better long-term protection from
stroke and other neurologic events than synthetic
patches. Although these differences proved to be sta-
tistically significant, it is conceivable that patients who
required obligatory synthetic patching because their
greater saphenous veins already had been harvested for
coronary bypass surgery or for infrainguinal revascu-
larization could represent a population at higher risk
for neurologic complications because of the extent and
severity of their vascular disease. This is an important
clinical area that begs further investigation.
We thank Becky Roberts for maintaining the database
for this study and Fran Federico who assisted with the
preparation of the manuscript. We also thank Geoffrey S.
Cox, FRACS, (Melbourne, Australia) and Timothy M.
Fig 4. Kaplan-Meier method estimates of freedom from any first ipsilateral stroke. Numbers
in parentheses indicate patients still eligible for consideration.
JOURNAL OF VASCULAR SURGERY
Volume 30, Number 4 Tretter et al 629
Sullivan, MD, (Greenville, SC) who contributed patients
to this series while members of our department in 1991 to
1992 and 1994 to 1995, respectively.
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APPENDIX. UNIVARIATE ANALYSIS OF 30-DAY COMBINED STROKE AND MORTALITY RATES
Variable No. of patients No. of events CSM (%) P value
Total 314 21 6.7 —
Semi-elective 287 17 5.9 .09
Emergent 27 4 15
Interval from presentation to operation .99
0 to 1 day 150 10 6.7
≥2 days 164 11 6.7
Sex .35
Male 209 12 5.7
Female 105 9 8.6
Age (years) .12
<60 47 0 —
60 to 69 113 11 9.7
70 to 79 114 7 6.1
≥80 40 3 7.5
Diabetes* .22
None (0) 243 14 5.8
Mild (1) 53 5 9.4
Moderate (2) 18 2 11
Tobacco use* .41
None (0) 190 10 5.3
Mild (1) 42 3 7.1
Moderate (2) 36 6 17
Severe (3) 46 2 4.3
Hypertension* .08
None (0) 121 7 5.8
Mild (1) 130 6 4.6
Moderate (2) 54 6 11
Severe (3) 9 2 22
Hyperlipidemia* .92
None (0) 211 14 6.6
Mild (1) 51 3 5.9
Moderate (2) 5 1 20
Severe (3) 47 3 6.4
Cardiac* .005
None (0) 133 5 3.8
Mild (1) 90 5 5.6
Moderate (2) 80 8 10
Severe (3) 11 3 27
Renal* .14
None (0) 257 16 6.2
Mild (1) 49 3 6.1
Moderate (2) 4 1 25
Severe (3) 4 1 25
Pulmonary* .001
None (0) 288 15 5.2
Mild (1) 17 2 12
Moderate (2) 4 1 25
Severe (3) 5 3 60
Surgical indications .68
Asymptomatic stenosis 29 1 3.4
Transient symptoms 227 15 6.6
Completed stroke 35 3 8.6
Unstable stroke 7 1 14
All others 16 1 6.3
Preoperative symptoms .42
Yes 285 20 7.0
No 29 1 3.4
Angiographic stenosis .99
≤79% 59 4 6.8
≥80% 249 17 6.8
Contralateral stenosis .2
≤79% 225 18 8.0
≥80% 77 3 3.9
Ulcerated plaque .99
Yes 64 4 6.3
No 243 17 7.0
Continued
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APPENDIX. UNIVARIATE ANALYSIS OF 30-DAY COMBINED STROKE AND MORTALITY RATES
Variable No. of patients No. of events CSM (%) P value
Intraluminal thrombus .48
Yes 9 1 11
No 298 20 6.7
Intracranial disease .52
Yes 44 4 9.1
No 263 17 6.4
Ulcer, thrombus, or intracranial disease .96
Yes 103 7 6.8
No 211 14 6.6
Operated side .64
Right 164 12 7.3
Left 150 9 6.0
Previous ipsilateral carotid endarterectomy .10
Yes 28 4 14
No 286 17 5.9
Intraoperative shunt
Yes 307 21 6.8 .99
No 7 0 —
Carotid patch
Vein 247 15 6.4 .44
Synthetic 55 5 9.1
All others 12 1 8.3
Preoperative heparin therapy
Yes 210 15 7.1 .64
No 104 6 5.8
Postoperative heparin therapy
Yes 18 1 5.6 .99
No 296 20 6.8
CSM, Combined stroke and mortality rate.
*Also tested categorically (yes/no).
Numbers in parentheses represent the risk factor classification from the Society for Vascular Surgery and the North American Chapter
of the International Society for Cardiovascular Surgery (Table I).2
